212 related articles for article (PubMed ID: 18973197)
1. Prognostic significance of c-Met expression in glioblastomas.
Kong DS; Song SY; Kim DH; Joo KM; Yoo JS; Koh JS; Dong SM; Suh YL; Lee JI; Park K; Kim JH; Nam DH
Cancer; 2009 Jan; 115(1):140-8. PubMed ID: 18973197
[TBL] [Abstract][Full Text] [Related]
2. c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme.
Liu W; Fu Y; Xu S; Ding F; Zhao G; Zhang K; Du C; Pang B; Pang Q
J Clin Neurosci; 2011 Jan; 18(1):119-21. PubMed ID: 20832323
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepatocyte growth factor and c-MET in skull base chordoma.
Naka T; Kuester D; Boltze C; Scheil-Bertram S; Samii A; Herold C; Ostertag H; Krueger S; Roessner A
Cancer; 2008 Jan; 112(1):104-10. PubMed ID: 17948912
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
Miyata Y; Sagara Y; Kanda S; Hayashi T; Kanetake H
Hum Pathol; 2009 Apr; 40(4):496-504. PubMed ID: 19121849
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma.
Diomedi-Camassei F; McDowell HP; De Ioris MA; Uccini S; Altavista P; Raschellà G; Vitali R; Mannarino O; De Sio L; Cozzi DA; Donfrancesco A; Inserra A; Callea F; Dominici C
Clin Cancer Res; 2008 Jul; 14(13):4119-27. PubMed ID: 18593989
[TBL] [Abstract][Full Text] [Related]
7. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance of cystatin C expression in gliomas.
Nakabayashi H; Hara M; Shimuzu K
Hum Pathol; 2005 Sep; 36(9):1008-15. PubMed ID: 16153465
[TBL] [Abstract][Full Text] [Related]
9. Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.
Buccoliero AM; Caldarella A; Gheri CF; Taddei A; Paglierani M; Pepi M; Mennonna P; Taddei GL
Clin Neuropathol; 2006; 25(2):59-66. PubMed ID: 16550738
[TBL] [Abstract][Full Text] [Related]
10. Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features.
Samaras V; Stamatelli A; Samaras E; Arnaoutoglou C; Arnaoutoglou M; Stergiou I; Konstantopoulou P; Varsos V; Karameris A; Barbatis C
Pathol Res Pract; 2009; 205(11):765-73. PubMed ID: 19616898
[TBL] [Abstract][Full Text] [Related]
11. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
Gunal A; Onguru O; Safali M; Beyzadeoglu M
Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
[TBL] [Abstract][Full Text] [Related]
12. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4372-5. PubMed ID: 16303922
[TBL] [Abstract][Full Text] [Related]
13. Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.
Hilton DA; Penney M; Pobereskin L; Sanders H; Love S
Histopathology; 2004 Jun; 44(6):555-60. PubMed ID: 15186270
[TBL] [Abstract][Full Text] [Related]
14. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
15. c-Met activation in lung adenocarcinoma tissues: an immunohistochemical analysis.
Nakamura Y; Niki T; Goto A; Morikawa T; Miyazawa K; Nakajima J; Fukayama M
Cancer Sci; 2007 Jul; 98(7):1006-13. PubMed ID: 17459054
[TBL] [Abstract][Full Text] [Related]
16. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma.
Naka T; Boltze C; Samii A; Samii M; Herold C; Ostertag H; Iwamoto Y; Oda Y; Tsuneyoshi M; Kuester D; Roessner A
Histopathology; 2009 Apr; 54(5):607-13. PubMed ID: 19302530
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
19. The significance of prohibitin and c-Met/hepatocyte growth factor receptor in the progression of cervical adenocarcinoma.
Tsai HW; Chow NH; Lin CP; Chan SH; Chou CY; Ho CL
Hum Pathol; 2006 Feb; 37(2):198-204. PubMed ID: 16426920
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme.
Chang CY; Li MC; Liao SL; Huang YL; Shen CC; Pan HC
J Clin Neurosci; 2005 Nov; 12(8):930-3. PubMed ID: 16326273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]